Health Tech & Biotech: Moderna’s mRNA flu vaccine (mFLUSIVA) wins FDA approval for adults 50+, adding another mRNA option for older Australians who rely on seasonal protection. Cancer Care Watch: Iovance Biotherapeutics shares jump after record Q2 revenue, driven by strong Amtagvi demand—another sign investors are tracking next-gen cell therapies closely. Medical Devices Market Pulse: New market reports flag continued growth in emergency medical services products, endovascular stent grafts, EUS-guided fine needle aspiration, endometrial ablation devices, and epigenetics—useful context for Australia’s health tech buyers. Digital Infrastructure: Timor-Leste commercially launches its first international subsea cable link to Australia via Vocus, a big step for regional connectivity and competition beyond satellite. Australia-Asia Policy: Bangladesh and Australia reaffirm trade, skills, and research cooperation, including plans for longer-term training and a regional research hub. Cybersecurity Anxiety: Reports warn AI could expose private secrets by linking leaked data—another reminder for Australians to tighten account and privacy hygiene. Local Life & Community: Ageing Australia marks Aged Care Employee Day, spotlighting the 450,000+ workers keeping older Australians supported and connected.